F-18 FDG Whole-Body Positron Emission Tomography Scan in Primary Breast Sarcoma
- 1 September 1998
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 23 (9), 604-608
- https://doi.org/10.1097/00003072-199809000-00009
Abstract
Three patients with primary breast sarcoma showed intense F-18 FDG breast uptake on the whole-body scan. In two patients the uptake was irregular and associated with cold foci that corresponded to hypodense lesions noted on the chest CT; these represented areas of pathologically demonstrated tumor necrosis. There was also intense FDG uptake in pulmonary, axillary, and supraclavicular lymph node metastases. All lesions were confirmed by CT scan of the chest. Thus F-18 FDG positron emission tomographic scanning accurately staged the tumors in these two patients, and it documented local recurrence in the third patient. Histopathologic examination showed evidence of a high-grade sarcoma, a primary rhabdomyosarcoma, and a malignant cystosarcoma phyllodes of the breast. Similar to breast carcinoma, F-18 FDG whole-body positron emission tomographic imaging could be useful in diagnosing and staging primary breast sarcomas.Keywords
This publication has 3 references indexed in Scilit:
- BREAST SARCOMASurgical Clinics of North America, 1996
- PET FDG studies in oncologyNuclear Medicine and Biology, 1994
- Positron Emission Tomography of Glucose Metabolism in Breast CancerAnnals of the New York Academy of Sciences, 1993